Derivatives of pentamidine designed to target the Leishmania lipophosphoglycan

No Thumbnail Available
File version
Author(s)
Kramp, KL
DeWitt, K
Flora, JW
Muddiman, DC
Slunt, KM
Houston, TA
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2005
Size
File type(s)
Location
License
Abstract

The Leishmania lipophosphoglycan (LPG) is the most abundant cell surface glycoconjugate of a family of infectious protozoa. Pentamidine, a common drug used in the treatment of Leishmania infections, has been modified with boronic acids so that it might bind more selectively to the phosphodisaccharide repeating unit of the LPG. This could serve to target the drug to the protozoan surface and increase its efficacy in vivo

Journal Title

Tetrahedron Letters

Conference Title
Book Title
Edition
Volume

46

Issue
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject

Medicinal and biomolecular chemistry

Organic chemistry

Persistent link to this record
Citation
Collections